TXG Operating Cash Flow (Statement)
10X Genomics Inc Class A · Operating Cash Flow (Statement)
TXG Operating Cash Flow (Statement)
Latest reported$127.09Mperiod ending
TXG TTM Cash from Operations (-$76.41M → $127.09M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TXG operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 127,085,000 | |
| 127,819,000 | |
| 136,050,000 | |
| 88,525,000 | |
| 66,952,000 | |
| 56,740,000 | |
| 6,664,000 | |
| 39,170,000 | |
| -7,775,000 | |
| -26,797,000 | |
| -15,197,000 | |
| -27,232,000 | |
| -11,492,000 | |
| -16,929,000 | |
| -33,606,000 | |
| -41,524,000 | |
| -58,176,000 | |
| -38,093,000 | |
| -21,373,000 | |
| -157,353,000 | |
| -186,766,000 | |
| -219,404,000 | |
| -217,898,000 | |
| -81,023,000 | |
| -10,868,000 | |
| 22,733,000 | |
| 34,627,000 | |
| -23,072,000 | |
| -42,782,000 | |
| -56,978,000 | |
| -76,409,000 |